Clinical Trial Update: Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial comparing vortioxetine to placebo in adults with major depressive disorder and comorbid social anxiety disorder. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Social Anxiety Disorder

Drugs mentioned

• TRINTELLIX (Vortioxetine)

Snippet

Sponsor: The Medical Research Network | Conditions: Social Anxiety Disorder, Major Depressive Disorder | Phase 4 | Status: UNKNOWN